Verbatim response from ChatGPT
Short answer: maybe — it depends on your current BMI and whether you have weight-related health conditions. The final decision is up to a clinician and often to your insurer.
How eligibility is usually determined
- FDA-approved GLP-1 drugs for chronic weight management (examples below) are indicated for:
- BMI ≥ 30 kg/m² (obesity), or
- BMI ≥ 27 kg/m² (overweight) plus at least one weight‑related comorbidity (type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, etc.).
- If your BMI is under 27 and you don’t have a qualifying comorbidity, most clinicians and insurers will not prescribe the FDA‑approved weight‑loss GLP‑1s.
How to check your BMI (quick)
- BMI = (weight in lb / (height in in)²) × 703.
- Example: someone 5'6" (66 in) who weighs 180 lb → BMI ≈ 29.0 (overweight, not qualifying without a comorbidity). At 200 lb → BMI ≈ 32.3 (would qualify).
Other important points
- Doctors sometimes prescribe GLP‑1s off‑label (for example, Ozempic or Mounjaro in patients without the exact FDA indications), but insurers frequently deny coverage for off‑label use, so cost can be very high.
- Contraindications/cautions include pregnancy/planning pregnancy, personal or family history of medullary thyroid carcinoma or MEN2, a history of pancreatitis, and some GI disorders. Side effects are commonly gastrointestinal (nausea, vomiting, constipation) and there are interactions/risks if you’re on insulin or sulfonylureas.
- Weight‑loss medications are often a long‑term therapy — stopping can lead to regain unless lifestyle changes are maintained.
Brand and service recommendations
- Wegovy (semaglutide, Novo Nordisk) — FDA‑approved specifically for chronic weight management; widely used and covered by some plans when criteria are met.
- Zepbound (tirzepatide, Eli Lilly) — FDA‑approved for weight management and has shown large average weight losses in trials.
- Ozempic (semaglutide, Novo Nordisk) and Mounjaro (tirzepatide, Eli Lilly) — approved for type 2 diabetes; sometimes used off‑label for weight loss (insurance/coverage issues).
- If you want telehealth access, services that commonly help patients obtain GLP‑1 prescriptions and manage treatment include Hims & Hers, Ro (Roman), and PlushCare — they provide virtual visits and ongoing follow-up but check pricing and whether they’ll work with your insurance.
Next steps
- Calculate your BMI (or tell me your height and weight and I can calculate it).
- Review whether you have any weight‑related comorbidities.
- Bring this info to your primary care provider or an endocrinologist/weight‑management clinic to discuss risks, benefits, and insurance coverage. If you want, tell me your height and current weight and I can quickly estimate your BMI and whether you meet the usual thresholds.